Monuril (Fosfomycin)

Fosfomycin blocks the enzyme MurA, preventing the formation of N‑acetylmuramic acid, an essential building block of bacterial peptidoglycan. Without this precursor, the bacterial cell wall cannot be assembled, leading to cell lysis and death, especially against common Gram‑negative urinary pathogens.

The prescribed dose of Monuril is determined by the treating clinician. In most adult cases, a single 3 g oral dose of the reconstituted suspension is used, but the exact regimen, including any adjustments for renal function, must be set by a qualified healthcare professional.

The pregnancy safety category for fosfomycin is not definitively established. Use during pregnancy or lactation should only occur when the potential benefit justifies any possible risk to the fetus or infant, and it must be decided by the prescribing physician after a careful assessment.

To request Monuril, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with agents such as nitrofurantoin or trimethoprim‑sulfamethoxazole, fosfomycin offers a convenient single‑dose regimen and retains activity against many multidrug‑resistant strains. However, susceptibility patterns vary, and clinicians should consider local resistance data when selecting therapy.

Monuril should be stored below 25 °C in its original packaging. Protect the powder from moisture and direct sunlight. Once reconstituted, the suspension should be used promptly according to the prescribing information and any remaining product discarded if not used within the recommended time frame.

The oral powder is mixed with a specified volume of clean water to create a suspension, as indicated in the package insert. The resulting solution is taken orally as a single dose, preferably on an empty stomach, unless otherwise directed by the prescriber.

Serious adverse events include severe allergic reactions such as rash, angioedema or anaphylaxis, and Clostridioides difficile‑associated colitis. Patients with significant renal impairment may experience worsening kidney function, and rare cases of liver injury or hematologic abnormalities have been reported.

Monuril is contraindicated in individuals with a known hypersensitivity to fosfomycin or any of its excipients. It should be used with caution, or avoided, in patients with severe renal impairment, and it is not recommended for children unless specifically prescribed by a pediatric specialist.